Researchers identify unique cellular traits in aggressive colorectal cancer in young adults

A study published in Nature Medicine has revealed that colorectal cancer in patients under 50 exhibits distinct cellular and genetic characteristics compared to older patients. Researchers analyzed 189 tumors from individuals aged 29 to over 90, using RNA sequencing to map gene activity across more than 850,000 cells.

The findings suggest that the tumor microenvironment in younger patients may be more aggressive, potentially explaining why these cancers are often diagnosed at advanced stages and why they are more resistant to standard chemotherapy and immunotherapy. Kimmie Ng, a researcher at the Dana-Farber Cancer Institute, noted that younger patients, particularly those under 35, often face lower survival rates despite being generally healthier and receiving intensive treatments.

Ana C. Anderson of Harvard Medical School emphasized the urgency of understanding these biological differences as the incidence of colorectal cancer in young adults continues to rise. In the United States, colorectal cancer is currently the leading cause of cancer-related deaths for individuals under the age of 50.